Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regagliptin plus metformin vs placebo plus metformin in type 2 diabetes
CTR20131412Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of retagliptin in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Mar 2014; status: completed.
02
Drugs
retagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20131412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131412.